CVM - Cel-Sci Corpora Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (1.53%) AMZN (-0.02%) TTD (3.1%) WMT (-0.04%) AMD (-0.84%) AGS (54.6%) ADT (13.83%) AAPL (0.73%) O (6.69%) NFLX (-0.11%) MU (-4.48%) MTBCP (2.68%) MITT (0.59%) LULU (3.83%) LPSN (12.85%) GRPN (-0.64%) GDXJ (9.46%) FLS (-5.4%) FB (0.53%) FANG (-6.99%) EXPE (3.09%) ETHUSD (%) ENDP (8.1%) CRM (2.27%) CAPR (-8.43%)

CVM - Cel-Sci Corporation

$12.11 0.32[2.72%]

15 mins delayed data

People also watch : CASI | CYTR | JNJ | XNCR | EBS | TEVA

+Watchlist

2 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$11.79	Open	$11.62
Volume	441.9K	Market Cap	146.61M
Yield		Last Dividend

Day

52 Week

Important Update For CEL-SCI Corporation...	04/08/20
VIENNA, Va.--(BUSINESS WIRE)--Important update for CEL-SCI Corporation Annual Meeting of Shareholders.

CVR Medical : Announces Trish Howell to ...	03/16/20
VANCOUVER, BC / March 10, 2020 / / CVR Medical Corp. a Canadian listed and US based healthcare company in the medical device sector announces the resi...

CVR Medical : Announces Acquisition of a...	03/16/20
VANCOUVER, BC / March 16, 2020 / / CVR Medical Corp. a Canadian listed and US based healthcare company in the medical device sector announces the plan...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP...	03/10/20
NEW YORK, NY / ACCESSWIRE / March 10, 2020 / Levi & Korsinsky announces it has commenced an investigation of CEL-SCI Corporation (NYSE:CVM) concerning...

CEL-SCI Corporation Reports First Quarte...	02/10/20
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation reports first quarter fiscal 2020 financial results.

CVR Medical : Provides Corporate Update ...	01/06/20
VANCOUVER, BC / January 6, 2020 / CVR Medical Corp. a Canadian listed and US based healthcare company in the medical device sector provides the follow...

US??? CEL-SCI Corporation closes $5.5m u...	12/27/19
Mubasher: American biotechnology company CEL-SCI Corporation has announced that it closed an underwritten public offering of 606,395 shares of its com...

CEL-SCI Dips on Stock Offering	12/24/19
CEL-SCI Corporation (NYSE:CVM) reported a common stock offering Tuesday. The company, located in Vienna, Virginia, is a Phase 3 cancer immunotherapy c...

4 Stocks To Watch For December 24, 2019	12/24/19
Some of the stocks that may grab investor focus today are: CEL-SCI Corporation (NYSE: CVM ) reported a common stock offering. However, size of the off...

CEL-SCI: Why No Discussions About Yervoy...	12/04/19
CEL-SCI Corporation (CVM) is a small-cap (~$250million), clinical-stage cancer bio-pharmaceutical company. Multikine, a cocktail combination of cytoki...

CVR Medical : Announces Revocation of Ce...	11/05/19
DENVER, NC / November 5th, 2019, / CVR Medical Corp. a Canadian listed and US based healthcare company in the medical device sector is pleased to anno...

CEL-SCI Corporation to Present at Dawson...	10/29/19
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation to present at Dawson James Securities 5th Annual Small Cap Growth Conference.

The Dangers Of CEL-SCI Corporation	05/16/19
No summary available.

CEL-SCI (CVM) Presents At BIO CEO & Inve...	02/12/19
The following slide deck was published by Cel-Sci Corporation in conjunction with this event.

ANALYST RATINGS

1 analyst ratings (Last 6 months)

100.00 %

Strong Buy + Buy

Price Target (PT)

Buy rating	01/13/20
H.C. Wainwright initiates coverage with Buy rating and announces Price Target of $18.00

EARNINGS

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

TRADERS TRACKING $CVM

Service Name	Trader	% Success
Arbitrage Trade Analytics	Royce Wells	71.00 %	Subscribe

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.